The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 864.00
Bid: 834.00
Ask: 856.00
Change: 36.00 (4.35%)
Spread: 22.00 (2.638%)
Open: 840.00
High: 876.00
Low: 822.00
Prev. Close: 828.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

24 May 2023 07:00

RNS Number : 4155A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"In an ongoing challenging environment, we continue to demonstrate the strength of MAB's model and resilience in adviser numbers and mortgage completions against a significantly weaker market backdrop. This positions the Group well for subsequent market recovery.

"Our Adviser numbers have stabilised in Q2 at 2,1221 advisers on 19 May 2023. We expect our existing Appointed Representative firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves further when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty. Our pipeline of incoming new Appointed Representatives has grown strongly this year.

"As expected, the value of completions in the wider market was slower in Q1 2023 with a 21% reduction in new mortgage lending2 compared to last year. MAB's total mortgage completions for Q1 2023 were broadly stable at £5.8bn (2022: £5.9bn). Our new mortgage completions were £4.4bn (2022: £4.9bn) with the balance of £1.4bn (2022: £1.0bn) being Product Transfers. We have continued to grow our market share, which has been achieved despite a reduction in the number of advisers since Q4 2022.

"During the six months following the mini-budget, new mortgage approvals across the market were down by as much as 40% versus the prior year. There are early signs of increasing activity and mortgage approval levels have now gradually started to improve, but remain significantly lower than for the equivalent period last year.

"MAB's performance, despite challenging market conditions, remains in line with the Board's expectations with further improvement expected in the second-half of the year."

 

1 Includes 139 Fluent advisers as at 19 May 2023 (76 advisers in the first charge mortgages division, 49 in the secured personal loans division, 8 in the later life division, and 6 in the bridging finance division). Includes a total of 183 advisers at 19 May 2023 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 UK Finance, product transfer lending figures not available until 7 June.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFWDEDSEEI
Date   Source Headline
20th Nov 20204:36 pmRNSPrice Monitoring Extension
20th Nov 20202:03 pmRNSHolding(s) in Company
19th Nov 20205:10 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSDividend Declaration
16th Nov 202012:54 pmRNSDirector/PDMR Shareholding
30th Oct 202012:29 pmRNSDirector/PDMR Shareholding
30th Oct 202011:00 amRNSTotal Voting Rights
14th Oct 20205:01 pmRNSDirector/PDMR Shareholding
12th Oct 20204:15 pmRNSHolding(s) in Company
9th Oct 202012:55 pmRNSIssue of Equity and PDMR dealing
30th Sep 20201:30 pmRNSTotal Voting Rights
30th Sep 202011:29 amRNSDirector/PDMR Shareholding
29th Sep 20207:00 amRNSMAB Australia: new joint venture partner
29th Sep 20207:00 amRNSInterim Results
17th Sep 202010:21 amRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSLaunch of Mortgage Advice Bureau Later Life
28th Aug 202012:11 pmRNSDirector/PDMR Shareholding
14th Aug 20202:39 pmRNSDirector/PDMR Shareholding
31st Jul 20201:38 pmRNSDirector/PDMR Shareholding
31st Jul 20201:00 pmRNSTotal Voting Rights
30th Jul 202010:39 amRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSTrading Update
24th Jul 20209:30 amRNSGrant of Options and PDMR Dealing
14th Jul 20204:21 pmRNSDirector/PDMR Shareholding
9th Jul 20204:40 pmRNSSecond Price Monitoring Extn
9th Jul 20204:35 pmRNSPrice Monitoring Extension
30th Jun 202012:27 pmRNSDirector/PDMR Shareholding
15th Jun 20205:35 pmRNSDirector/PDMR Shareholding
12th Jun 20201:30 pmRNSBlock listing Interim Review
2nd Jun 20203:37 pmRNSIssue of Equity and Total Voting Rights
1st Jun 20203:37 pmRNSDirector/PDMR Shareholding
29th May 20201:00 pmRNSTotal Voting Rights
26th May 20203:07 pmRNSResult of AGM
26th May 20207:00 amRNSAGM Statement
14th May 20204:49 pmRNSDirector/PDMR Shareholding
1st May 20206:18 pmRNSPosting of Report and Accounts and Notice of AGM
1st May 202011:58 amRNSHolding(s) in Company
30th Apr 20201:30 pmRNSTotal Voting Rights
30th Apr 202011:59 amRNSDirector/PDMR Shareholding
23rd Apr 20202:31 pmRNSDirector/PDMR Shareholding
23rd Apr 202011:46 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
14th Apr 20204:50 pmRNSDirector/PDMR Shareholding
8th Apr 20204:41 pmRNSSecond Price Monitoring Extn
8th Apr 20204:37 pmRNSPrice Monitoring Extension
31st Mar 202011:44 amRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSFCA Moratorium on Publication of Results
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20203:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.